TELADOC HEALTH, INC. Increase (Decrease) in Deferred Revenue
TELADOC HEALTH, INC. (TDOC) reported Increase (Decrease) in Deferred Revenue of $5.65 million for the 3-month period ending 2023-03-31, per its 10-Q filed 2023-05-02.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredRevenue · last filed 2023-05-02
- TELADOC HEALTH, INC. increase (decrease) in deferred revenue for the quarter ending 2023-03-31 was $5.65M, a 24.48% decline year-over-year.
- TELADOC HEALTH, INC. increase (decrease) in deferred revenue for the quarter ending 2022-12-31 was $2.93M, a 430.62% increase year-over-year.
- TELADOC HEALTH, INC. increase (decrease) in deferred revenue for the quarter ending 2022-09-30 was $1.49M, a 46.80% decline year-over-year.
- TELADOC HEALTH, INC. increase (decrease) in deferred revenue for the quarter ending 2022-06-30 was $3.34M, a 2710.08% increase year-over-year.
- TELADOC HEALTH, INC. increase (decrease) in deferred revenue for fiscal 2022 was $15.24M, a 25.85% decline from fiscal 2021.
- TELADOC HEALTH, INC. increase (decrease) in deferred revenue for fiscal 2021 was $20.55M, a 15.79% increase from fiscal 2020.
- TELADOC HEALTH, INC. increase (decrease) in deferred revenue for fiscal 2020 was $17.75M, a 268.66% increase from fiscal 2019.
- TELADOC HEALTH, INC. increase (decrease) in deferred revenue for fiscal 2019 was $4.82M, a 36.06% increase from fiscal 2018.
| Period end | Increase (Decrease) in Deferred Revenue 3 month | Increase (Decrease) in Deferred Revenue 6 month | Increase (Decrease) in Deferred Revenue 9 month | Increase (Decrease) in Deferred Revenue 12 month |
|---|---|---|---|---|
| 2023-03-31 | $5.65M 10-Q · filed 2023-05-02 | $8.58M derived: sum of 2 quarters · filed 2023-05-02 | $10.06M derived: sum of 3 quarters · filed 2023-05-02 | $13.41M derived: sum of 4 quarters · filed 2023-05-02 |
| 2022-12-31 | $2.93M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $4.42M derived: sum of 2 quarters · filed 2023-03-01 | $7.76M derived: sum of 3 quarters · filed 2023-03-01 | $15.24M 10-K · filed 2023-03-01 |
| 2022-09-30 | $1.49M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | $4.83M derived: sum of 2 quarters · filed 2022-11-02 | $12.31M 10-Q · filed 2022-11-02 | $12.86M derived: sum of 4 quarters · filed 2023-05-02 |
| 2022-06-30 | $3.34M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | $10.82M 10-Q · filed 2022-08-03 | $11.38M derived: sum of 3 quarters · filed 2023-05-02 | $14.17M derived: sum of 4 quarters · filed 2023-05-02 |
| 2022-03-31 | $7.48M 10-Q · filed 2023-05-02 | $8.03M derived: sum of 2 quarters · filed 2023-05-02 | $10.83M derived: sum of 3 quarters · filed 2023-05-02 | $10.95M derived: sum of 4 quarters · filed 2023-05-02 |
| 2021-12-31 | $552.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $3.35M derived: sum of 2 quarters · filed 2023-03-01 | $3.47M derived: sum of 3 quarters · filed 2023-03-01 | $20.55M 10-K · filed 2023-03-01 |
| 2021-09-30 | $2.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | $2.92M derived: sum of 2 quarters · filed 2022-11-02 | $20.00M 10-Q · filed 2022-11-02 | $22.41M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-06-30 | $119.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | $17.20M 10-Q · filed 2022-08-03 | $19.61M derived: sum of 3 quarters · filed 2023-03-01 | $47.30M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-03-31 | $17.09M 10-Q · filed 2022-05-02 | $19.49M derived: sum of 2 quarters · filed 2023-03-01 | $47.18M derived: sum of 3 quarters · filed 2023-03-01 | $40.24M derived: sum of 4 quarters · filed 2023-03-01 |
| 2020-12-31 | $2.40M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $30.10M derived: sum of 2 quarters · filed 2023-03-01 | $23.16M derived: sum of 3 quarters · filed 2023-03-01 | $17.75M 10-K · filed 2023-03-01 |
| 2020-09-30 | $27.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-01 | $20.75M derived: sum of 2 quarters · filed 2021-11-01 | $15.35M 10-Q · filed 2021-11-01 | $13.46M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-06-30 | -$6.94M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-02 | -$12.35M 10-Q · filed 2021-08-02 | -$14.24M derived: sum of 3 quarters · filed 2022-02-28 | |
| 2020-03-31 | -$5.41M 10-Q · filed 2021-05-03 | -$7.30M derived: sum of 2 quarters · filed 2022-02-28 | ||
| 2019-12-31 | -$1.89M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $4.82M 10-K · filed 2022-02-28 | ||
| 2019-09-30 | $6.71M 10-Q · filed 2020-11-06 | |||
| 2018-12-31 | $3.54M 10-K · filed 2021-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SBC Medical Group Holdings Inc (SBC) | United States | $0.487B | |
| Airsculpt Technologies, Inc. (AIRS) | United States | $0.146B | -27.36 |
| LifeMD, Inc. (LFMD) | United States | $0.141B | 982.53 |